PRESTIGE BRANDS HOLDINGS, INC. (NYSE:PBH) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
On December 7, 2016, Prestige Brands Holdings, Inc. issued a
press release announcing the signing of an agreement for the sale
of the DermoPlast brand to Moberg Pharma AB, to the previously
announced exercise by Moberg Pharma of its option to purchase
DermoPlast. A copy of the press release is furnished as Exhibit
99.1 to this Current Report on Form 8-K and is incorporated
herein by reference.
Item 9.01 Financial Statements and
Exhibits.
| (d) | Exhibits |
See Exhibit Index immediately following the page.
About PRESTIGE BRANDS HOLDINGS, INC. (NYSE:PBH)
Prestige Brands Holdings, Inc. is engaged in the marketing, sales and distribution of over-the-counter healthcare and household cleaning products. The Company operates through three segments: North American Over-the-Counter (OTC) Healthcare; International Over-the-Counter Healthcare, and Household Cleaning. Its portfolio of OTC healthcare products includes core brands, such as DenTek specialty oral care products, Monistat women’s health products, Nix lice treatment, Chloraseptic sore throat treatments, Clear Eyes eye care products, Compound W wart treatments, The Doctor’s NightGuard dental protector, Little Remedies pediatric over-the-counter products, Efferdent denture care products, Luden’s throat drops, Dramamine motion sickness treatment, BC and Goody’s pain relievers, Beano gas prevention, Debrox earwax remover, and Gaviscon antacid. The Company’s portfolio of Household Cleaning brands includes the Chore Boy, Comet and Spic and Span brands. PRESTIGE BRANDS HOLDINGS, INC. (NYSE:PBH) Recent Trading Information
PRESTIGE BRANDS HOLDINGS, INC. (NYSE:PBH) closed its last trading session down -0.10 at 46.62 with 311,208 shares trading hands.